Search Results - "Cassata, Antonio"

Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics by Granata, Vincenza, Fusco, Roberta, Setola, Sergio Venanzio, Galdiero, Roberta, Maggialetti, Nicola, Patrone, Renato, Ottaiano, Alessandro, Nasti, Guglielmo, Silvestro, Lucrezia, Cassata, Antonio, Grassi, Francesca, Avallone, Antonio, Izzo, Francesco, Petrillo, Antonella

“…In this narrative review, we reported un up-to-date on the role of radiomics to assess prognostic features, which can impact on the liver metastases patient…”
Get full text

Correction: Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics by Granata, Vincenza, Fusco, Roberta, Setola, Sergio Venanzio, Galdiero, Roberta, Maggialetti, Nicola, Patrone, Renato, Ottaiano, Alessandro, Nasti, Guglielmo, Silvestro, Lucrezia, Cassata, Antonio, Grassi, Francesca, Avallone, Antonio, Izzo, Francesco, Petrillo, Antonella

Get full text

Gastrointestinal non colorectal cancer. Do elderly patients need a specific management? by Silvestro, Lucrezia, Nasti, Guglielmo, Ottaiano, Alessandro, Montano, Massimo, Casaretti, Rossana, Avallone, Antonio, Berretta, Massimiliano, Romano, Carmela, Cassata, Antonio, Tafuto, Salvatore, Iaffaioli, Rosario Vincenzo

“…Elderly patients (65 years and over) develop often, sometimes predominantly , esophageal, gastro esophageal junction, gastric and pancreatic cancer…”
Get more information

Double-Wall Nanotubes and Graphene Nanoplatelets for Hybrid Conductive Adhesives with Enhanced Thermal and Electrical Conductivity by Messina, Elena, Leone, Nancy, Foti, Antonino, Di Marco, Gaetano, Riccucci, Cristina, Di Carlo, Gabriella, Di Maggio, Francesco, Cassata, Antonio, Gargano, Leonardo, D’Andrea, Cristiano, Fazio, Barbara, Maragò, Onofrio Maria, Robba, Benedetto, Vasi, Cirino, Ingo, Gabriel Maria, Gucciardi, Pietro Giuseppe

“…Improving the electrical and thermal properties of conductive adhesives is essential for the fabrication of compact microelectronic and optoelectronic power…”
Get full text

Analysis of liquid biopsies from metastatic colorectal carcinoma (mCRC) patients (pts) enrolled in the ERMES clinical trial by Normanno, Nicola, Barone, Carlo, Maiello, Evaristo, Di Costanzo, Francesco, Cassata, Antonio, Tamburini, Emiliano, Tonini, Giuseppe, Bordonaro, Roberto, Rosati, Gerardo, Zaniboni, Alberto, Lonardi, Sara, Ferrari, Daris, Frassineti, Giovanni Luca, Tamberi, Stefano, Pisconti, Salvatore, Di Fabio, Francesca, Forgione, Laura, Rachiglio, Anna Maria, Pasquale, Raffaella, Pinto, Carmine

“…Abstract only…”
Get full text

Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC by Pinto, Carmine, Normanno, Nicola, Orlandi, Armando, Fenizia, Francesca, Damato, Angela, Maiello, Evaristo, Tamburini, Emiliano, Di Costanzo, Francesco, Tonini, Giuseppe, Bilancia, Domenico, Corsi, Domenico, Pisconti, Salvatore, Ferrau, Francesco, Gori, Stefania, Daniele, Bruno, Zaniboni, Alberto, Soto Parra, Héctor, Frassinetti, Giovanni Luca, Iaffaioli, Rosario Vincenzo, Zampino, Maria Giulia, Repetto, Lazzaro, Calegari, Maria Alessandra, Barone, Carlo

“…The optimal duration and intensity of first-line therapy in metastatic colorectal cancer patients once they have achieved an objective response is…”
Get full text

Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS-mutated metastatic colorectal cancer: the REVOLUTION study protocol by Avallone, Antonio, Piccirillo, Maria Carmela, Di Gennaro, Elena, Romano, Carmela, Calabrese, Filomena, Roca, Maria Serena, Tatangelo, Fabiana, Granata, Vincenza, Cassata, Antonio, Cavalcanti, Ernesta, Maurea, Nicola, Maiolino, Piera, Silvestro, Lucrezia, De Stefano, Alfonso, Giuliani, Francesco, Rosati, Gerardo, Tamburini, Emiliano, Aprea, Pasquale, Vicario, Valeria, Nappi, Anna, Vitagliano, Carlo, Casaretti, Rossana, Leone, Alessandra, Petrillo, Antonella, Botti, Gerardo, Delrio, Paolo, Izzo, Francesco, Perrone, Francesco, Budillon, Alfredo

“…Background: Despite effective treatments, metastatic colorectal cancer (mCRC) prognosis is still poor, mostly in RAS-mutated tumors, thus suggesting the need…”
Get full text

Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in by Pinto, Carmine, Normanno, Nicola, Orlandi, Armando, Fenizia, Francesca, Damato, Angela, Maiello, Evaristo, Tamburini, Emiliano, Di Costanzo, Francesco, Tonini, Giuseppe, Bilancia, Domenico, Corsi, Domenico, Pisconti, Salvatore, Ferrau, Francesco, Gori, Stefania, Daniele, Bruno, Zaniboni, Alberto, Soto Parra, Héctor, Frassinetti, Giovanni Luca, Iaffaioli, Rosario Vincenzo, Cassata, Antonio, Zampino, Maria Giulia, Repetto, Lazzaro, Calegari, Maria Alessandra, Barone, Carlo

“…The optimal duration and intensity of first-line therapy in metastatic colorectal cancer patients once they have achieved an objective response is…”
Get full text

Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first‐line treatment in metastatic colorectal carcinoma by Bajetta, Emilio, Di Bartolomeo, Maria, Mariani, Luigi, Cassata, Antonio, Artale, Salvatore, Frustaci, Sergio, Pinotti, Graziella, Bonetti, Andrea, Carreca, Ignazio, Biasco, Guido, Bonaglia, Luigi, Marini, Giovanni, Iannelli, Antonio, Cortinovis, Diego, Ferrario, Ermina, Beretta, Elena, Lambiase, Antonio, Buzzoni, Roberto

“…BACKGROUND The aim of the current randomized Phase II study was to investigate the efficacy and safety of capecitabine combined with irinotecan as first‐line…”
Get full text

Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with -mutated metastatic colorectal cancer: the REVOLUTION study protocol by Antonio Avallone, Maria Carmela Piccirillo, Elena Di Gennaro, Carmela Romano, Filomena Calabrese, Maria Serena Roca, Fabiana Tatangelo, Vincenza Granata, Antonio Cassata, Ernesta Cavalcanti, Nicola Maurea, Piera Maiolino, Lucrezia Silvestro, Alfonso De Stefano, Francesco Giuliani, Gerardo Rosati, Emiliano Tamburini, Pasquale Aprea, Valeria Vicario, Anna Nappi, Carlo Vitagliano, Rossana Casaretti, Alessandra Leone, Antonella Petrillo, Gerardo Botti, Paolo Delrio, Francesco Izzo, Francesco Perrone, Alfredo Budillon

“…Background: Despite effective treatments, metastatic colorectal cancer (mCRC) prognosis is still poor, mostly in RAS -mutated tumors, thus suggesting the need…”
Get full text

5‐fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors by Bajetta, Emilio, Rimassa, Lorenza, Carnaghi, Carlo, Seregni, Ettore, Ferrari, Leonardo, Bartolomeo, Maria Di, Regalia, Enrico, Cassata, Antonio, Procopio, Giuseppe, Mariani, Luigi

“…BACKGROUND For patients with surgically untreatable neuroendocrine tumors (NETs), the optimal therapeutic approach remains undefined. Somatostatin analogs and…”
Get full text

Premenopausal breast cancer patients treated with a gonadotropin-releasing hormone analog alone or in combination with an aromatase inhibitor: a comparative endocrine study by Celio, L, Martinetti, A, Ferrari, L, Buzzoni, R, Mariani, L, Miceli, R, Seregni, E, Procopio, G, Cassata, A, Bombardieri, E, Bajetta, E

“…The combination of a GnRH analogue and an aromatase inhibitor can induce a complete estrogen blockade in premenopausal breast cancer patients. Twenty-one…”
Get more information

Oral doxifluridine plus levoleucovorin in elderly patients with advanced breast cancer by Bajetta, Emilio, Biganzoli, Laura, Carnaghi, Carlo, Bartolomeo, Maria Di, Spagnoli, Ivo, Cassata, Antonio, Galante, Emanuele, Mariani, Luigi, Stampino, Corrado Gallo, Buzzoni, Roberto

“…BACKGROUND There currently is no agreement regarding the appropriate treatment of elderly patients with advanced breast carcinoma (ABC). Doxifluridine…”
Get full text

Preliminary experience with high-dose cisplatin, reduced glutathione and natural interferon-alpha in dacarbazine-resistant malignant melanoma by Bajetta, E, Rimassa, L, Carnaghi, C, Del Vecchio, M, Celio, L, Cassata, A

“…The incidence of malignant melanoma is rapidly increasing in many countries, and when this disease has reached advanced stages, standard therapies have little…”
Get more information